Syneos Health, Inc.
SYNH · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -13.58 | 0.06 | -0.47 | 1.04 |
| FCF Yield | -1.18% | 0.08% | 2.65% | 2.28% |
| EV / EBITDA | 63.52 | 66.24 | 43.11 | 41.45 |
| Quality | ||||
| ROIC | 0.78% | 0.53% | 1.98% | 1.34% |
| Gross Margin | 21.57% | 19.77% | 23.40% | 23.83% |
| Cash Conversion Ratio | -42.47 | -0.42 | 2.23 | 1.52 |
| Growth | ||||
| Revenue 3-Year CAGR | 4.63% | 6.66% | 6.89% | 6.40% |
| Free Cash Flow Growth | -1,871.66% | -97.09% | -9.29% | 46.37% |
| Safety | ||||
| Net Debt / EBITDA | 24.88 | 28.44 | 18.31 | 15.45 |
| Interest Coverage | 1.11 | 1.36 | 3.77 | 5.32 |
| Efficiency | ||||
| Inventory Turnover | 9,829.02 | 0.00 | 0.00 | 9,693.18 |
| Cash Conversion Cycle | 100.47 | 97.44 | 98.63 | 100.45 |